We are proud to announce that Biomedica Italia and Bioventus signed a new Agreement for the distribution of Tenex Health in Italian territory.
Tenex health’s minimally invasive technology is designed to perform a percutaneous tenotomy or fasciotomy as well as it is a new revolutionary treatment for Diabetic foot ulcers (DFU).
“We are excited to expand our partnership with Bioventus launching an innovative technology that will reinforce our solutions portfolio in the orthopedics and in the Diabetic foot segments with the aim to improve quality of care and patient safety.”
Oscar Rizzi MD of Biomedica Italia